METHODS

Patient resources:
Research was approved by local Internal Review Boards and all patients provided written consent in advance of the study. The study design met the tenets of the Declaration of Helsinki and Association for Research in Vision and Ophthalmology guidelines. Participants were examined by an ophthalmologist and underwent an eye examination that included measurement of visual acuity, refractive error, and intraocular pressure as well as a slit-lamp examination of the anterior chamber and fundus examination. Axial eye length was measured in some patients with A-scan ultrasound (Alcon, Fort Worth, TX). Patients were diagnosed with nanophthalmos when short axial eye length (<20 mm) or significant hyperopia (spherical equivalent > +6.00) were observed in the absence of other ocular abnormalities. The control subjects showed no evidence of nanophthalmos. Some members of both pedigrees contributed DNA samples but were unavailable for examination, and medical records could not be obtained. These subjects are indicated on the pedigree drawing with stars ( Figure 1 ), and their affection status was determined according to the family history report.
Genetic studies: Venous blood samples were obtained from the participants for the study. Genomic DNA was extracted from peripheral whole blood using the QIAamp Blood Maxi Kit (Qiagen, Valencia, CA). Pedigree 991-F was analyzed with a genome-wide linkage analysis using Illumina 6K human mapping microarrays (Illumina, Santa Clara, CA), which examine 6,020 single nucleotide polymorphisms (SNPs). Sample processing and labeling were performed following the manufacturer's instructions. Genomic regions consistent with linkage were identified, and multipoint non-parametric linkage (NPL) scores were calculated using the MERLIN software package [9] . Penetrance and disease gene frequency were set to 99% and 0.001%, respectively.
Exome capture was performed on one member of pedigree 991-F (IV:3, Figure 1 ) with SureSelect Human All Exon v2 (Agilent, Santa Clara, CA) using the manufacturer's protocol. Paired-end, 50 nucleotide reads were obtained using a HiSeq2000 (Illumina, San Diego, CA) that achieved average exon coverage of greater than 50X.
T h e e n t i r e c o d i n g r e g io n of T M E M 98 ( N M_15544.2) was amplif ied f rom patient and control DNA using overlapping primer pairs in PCR reactions containing 12.5 ng of each patient's DNA, 1.25 μl of 10× buffer (100 mM Tris -HCL, pH 8.3, 500 mM KCl, 15 mM MgCl 2 ), 300 μM of each dCTP, dATP, dGTP and dTTP, 1 pmol of each primer, and 0.25 U Biolase polymerase (Biolase) in a 8.35 μl of PCR solution. Primer sequences are listed in Appendix 1. Amplified DNA was scanned for mutations with bidirectional DNA sequencing with an Applied Biosystems model 3730 automated sequencer as previously described [10] . The mutations that result in amino acid substitutions were evaluated using the BLOSUM62 matrix [11] , SIFT [12] , and PolyPhen2 [13] . 
RESULTS
Clinical features of nanophthalmos:
Ophthalmic examinations were performed on 20 members of two large nanophthalmos pedigrees (pedigree 991-F from the United States, Figure 1 ; pedigree 951-N from the Marianas Islands, Figure  2 ). Both pedigrees exhibit an autosomal dominant inheritance pattern with high penetrance that spans at least four generations. Six of ten examined members of pedigree 991-F were diagnosed with nanophthalmos while an additional three members had nanophthalmos according to the family history report. Mean axial eye lengths were 17.1 mm±0.31 mm for the available patients. Affected family members also had a high degree of hyperopia with spherical equivalent refractions of +13.0±0.89 diopters (Table 1 ). Unaffected family members had much less hyperopia (+0.71±0.81 diopters).
Eight of ten examined members of Pacific Islander pedigree 951-N had nanophthalmos and an average axial eye length of 17.4 mm±0.94 mm, while unaffected family members had more normal eye length (22.7±0.38 mm; Table  2 ). Along with short axial eye lengths, family members with nanophthalmos also had hyperopia with spherical equivalent refractions of +3.93±1.57 diopters. Three additional family members had nanophthalmos according to the family history report; however, they were not available for examinations, and no medical records could be obtained.
Genetic studies of nanophthalmos pedigrees:
DNA from 20 affected family members of pedigrees 991-F and 951-N was genotyped at 6,020 SNPs. The genotypes were evaluated for coinheritance with nanophthalmos using linkage analysis. In pedigree 991-F, a 20.2 Mbp segment of chromosome 17p12-q12, bounded by SNPs rs530664 and rs16523, was transmitted with nanophthalmos in all members of the family. An Figure 2 . Nanophthalmos pedigree 951-N from the Marianas Islands. Subjects with nanophthalmos are indicated with black symbols, while healthy subjects are indicated with white symbols. Gray symbols indicate unknown affection status. Diagnosis was made with a clinical exam or a review of the medical records for all available family members. Diagnosis of family members indicated with stars was determined by family history. The subjects who contributed a DNA sample for the study are indicated with an "X." overlapping 19.7 Mb section of chromosome 17, bounded by SNPs rs917541 and rs16523, was similarly coinherited with nanophthalmos in pedigree 951-N. These data suggest that the gene that causes autosomal dominant nanophthalmos in pedigrees 991-F and 951-N lies between SNPs rs917541 and rs16523 on chromosome 17 ( Figure 3 ). This pericentric region of chromosome 17 has previously been linked to autosomal dominant nanophthalmos in a Chinese pedigree [8] .
Exome sequencing was performed for patient IV:3 in pedigree 991-F (Figure 1 ) to identify the DNA sequence va r ia nts cont ai ned w it h i n t he linked genomic regions. Within the linked region on chromosome 17, four non-synonymous DNA sequence variations were detected in four genes, ZNF286A, ZNF287, SLC47A1 (OMIM 609832), and TMEM98 (Figure 3) . Each variant was evaluated as a potential nanophthalmos-causing mutation by testing the rest of pedigree 991-F for coinheritance with disease and evaluating the pathogenicity of the mutation using sequence analysis programs, including SIFT, PolyPhen, and BLOSUM62. Of the four variants, only the His196Pro mutation in TMEM98 was coinherited with nanophthalmos, absent from healthy family members, and had pathogenic scores on all three sequence analysis systems ( Table 3 ). The TMEM98 missense mutation in pedigree 991-F, His196Pro, produced a BLOSUM62 score of −2, a PolyPhen score of 0.998 (probably damaging), and a SIFT score of 0 (damaging). All indicate that this mutation is likely pathogenic ( Table 3) . As data from this experiment were being collected, another research group reported the discovery of an autosomal dominant nanophthalmos gene, trans membrane 98 gene (TMEM98), that was located within the same chromosome 17 locus linked with disease in our pedigree [4] (Figure 3) . Consequently, the TMEM98 gene has become the top candidate gene for causing glaucoma in our pedigrees.
Pedigree 951-N was subsequently analyzed for TMEM98 mutations. Eleven members with nanophthalmos and four healthy family members were tested for disease-causing mutations using Sanger DNA sequencing. A novel 34 bp heterozygous deletion was detected in all affected family members that spans the last 28 bp of exon 4 and the first 6 bp of intron 4 (c.694_721delAGAATGAAGACTGGATCGA AGATGCCTCgtaagg). This TMEM98 deletion eliminates a splice site and results in a premature termination of translation. The mutation is coinherited with nanophthalmos in pedigree 951-F and is absent from all healthy family members.
Sequence analysis of both TMEM98 mutations provided additional support for their pathogenicity. Neither the His196Pro mutation nor the 34 bp deletion was detected in public DNA sequence databases including the Exome Variation Server and the 1000 Genomes Project [14] . Both mutations span highly conserved sequences based on the UCSC Genome Browser and BlastP. The His196Pro mutation detected in pedigree 991-F alters a histidine amino acid that is highly conserved across many disparate species (Figure 4) , which provides additional support for the mutation's potential pathogenicity.
DISCUSSION
Some forms of nanophthalmos are inherited as a Mendelian trait and are caused primarily by a single gene. Several cases of recessive nanophthalmos have been attributed to mutations in the MFRP gene [7] . Recently, Awadalla and coworkers identified TMEM98 as the first autosomal dominant nanophthalmos gene. A missense mutation in the TMEM98 gene (A193P) was associated with autosomal dominant nanophthalmos in one large pedigree [4] .
TMEM98 encodes a transmembrane protein that has ubiquitous expression in humans [4] . Furthermore, Awadalla and coworkers demonstrated that TMEM98 is also produced within ocular tissues including the sclera, choroid, retinal pigment epithelium, and iris that may have central roles in the pathogenesis of nanophthalmos [4, 15] . Little is known about Exome sequencing identified four non-synonymous mutations in the chromosome 17 critical region. Mutations were evaluated for pathogenicity based on co-inheritance with nanophthalmos in pedigree 991-F and with three mutation analysis software packages. the function of the protein encoded by TMEM98; however, its expression in the sclera suggest that mutations may contribute to its pathologic thickening in nanophthalmos. Moreover, TMEM98 expression in tissues of the outflow pathway makes it plausible that TMEM98 mutations might contribute to the development of secondary glaucoma in nanophthalmos. The cause of the abnormally small eyes in nanophthalmos is unknown. However, identification and future studies of TMEM98 may provide new insights into the developmental mechanisms that determine eye size, scleral thickness, and risk for glaucoma.
In this study, we confirmed the association between TMEM98 mutations and nanophthalmos by reporting two novel TMEM98 mutations (His196Pro and c.694_721delAG AATGAAGACTGGATCGAAGATGCCTCgtaagg) in autosomal dominant pedigrees. Both TMEM98 mutations identified in our nanophthalmos pedigrees are coinherited with disease, absent from sequencing databases, alter conserved DNA sequences, and are judged likely to be pathogenic based on their destructive effects on the encoded TMEM98. Our contribution of two additional large nanophthalmos pedigrees with TMEM98 variants that are coinherited with disease greatly strengthens Awadalla and coworkers' discovery and assertion that mutations in TMEM98 cause nanophthalmos [4, 16] .
APPENDIX 1: OLIGO SEQUENCES FOR AMPLIFICATION OF TMEM98.
To access the data, click or select the words "Appendix 1."
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